Any adverse events relating to Baxter products should be reported to Baxter’s Pharmacovigilance team using the following contact details:
Phone: 01635 206360
Ensuring patient safety is extremely important to us and we take the safety of all our medicines and devices very seriously.
Adverse Events may also be reported to the MHRA; reporting forms and information can be found at www.mhra.gov.uk/yellowcard
Important safety links
Information on the correct use of Baxter fibrin sealants with spray application: www.baxterspraysafety.com
Information on the use of glucose monitors in patients using Extraneal: www.glucosesafety.com/cont-eu.html